US 11364245
Use of reboxetine to treat narcolepsy
granted A61KA61K31/5375A61P
Quick answer
US patent 11364245 (Use of reboxetine to treat narcolepsy) held by AXSOME THERAPEUTICS, INC. expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME THERAPEUTICS, INC.
- Grant date
- Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/5375, A61P, A61P25/02, A61P25/20